Książki na temat „POTENTIAL INHIBITORS”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych książek naukowych na temat „POTENTIAL INHIBITORS”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.
Casey, Lorraine A. The synthesis of potential enzyme inhibitors. Huddersfield: The Polytechnic, 1991.
Znajdź pełny tekst źródłaJohnson, N. B. Modified peptides as potential enzyme inhibitors. Manchester: UMIST, 1994.
Znajdź pełny tekst źródłaNoort, Daniël. Design, synthesis, and evaluation of potential inhibitors of UDP-glucuronosyltransferase. [The Netherlands: s.n.], 1992.
Znajdź pełny tekst źródłaInternational Symposium on Proteases: Potential Role in Health and Disease (2nd 1987 Rothenburg ob der Tauber, Germany). Proteases II: Potential role in health and disease. New York: Plenum Press, 1988.
Znajdź pełny tekst źródła1930-, Smith H. J., i Simons Claire, red. Proteinase and peptidase inhibition: Recent potential targets for drug development. London: Taylor & Francis, 2002.
Znajdź pełny tekst źródłaWiggins, Karen. Synthesis of potential phospholipase A2 inhibitors based on manoalide. Norwich: University of East Anglia, 1989.
Znajdź pełny tekst źródłaYap, Chee Hoong. Potential inhibitors of dihydrofolate reductase: Synthesis and NMR spectroscopy. Birmingham: University of Aston. Department of Molecular Sciences (Chemistry), 1985.
Znajdź pełny tekst źródła1943-, Greenwald Robert A., Golub Lorne M i New York Academy of Sciences., red. Inhibition of matrix metalloproteinases: Therapeutic potential. New York, N.Y: New York Academy of Sciences, 1994.
Znajdź pełny tekst źródłaQuibell, Martin. The synthesis of azaglutamine containing peptides as potential inhibitors of the picornavirus 3C proteinase. Birmingham: University of Birmingham, 1991.
Znajdź pełny tekst źródłaSurfraz, Mohammad Bashir-Uddin. Design and synthesis of novel inhibitors of Inositol Monophosphatase: Potential drug candidates in the treatment of Bipolar Disorder. Birmingham: University of Birmingham, 2003.
Znajdź pełny tekst źródłaIsaacs, Stuart Neal. Premeditated enzyme inactivation: The development of mechanism-based irreversible inhibitors of glyoxalase I as potential anti-cancer agents. [New Haven: s.n.], 1985.
Znajdź pełny tekst źródłaMorlin, A. J. G. The preparation of some chiral 2-hydroxycarboxylic acids and their use in the synthesisof potential angiotensin converting enzyme inhibitors. Norwich: University of East Anglia, 1993.
Znajdź pełny tekst źródłaWong, Philip. The potential of two new inhibitors of mechanisms that regulate intracellular pH, cariporide and S3705, to inhibit tumour cell proliferation. Ottawa: National Library of Canada, 2001.
Znajdź pełny tekst źródłaAthanasius, Anagostou, Dainiak Nicholas, Najman Albert i International Conference on Negative Regulators of Hematopoiesis, (2nd : 1990 : Providence, R.I.), red. Negative regulators of hematopoiesis: Studies of their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.
Znajdź pełny tekst źródłaR, Vane John, Botting Regina M, William Harvey Research Conference (1997 : Phuket, Thailand) i William Harvey Research Conference (1998 : Boston, Mass.), red. Clinical significance and potential of selective COX-2 inhibitors: The combined proceedings of the William Harvey Conferences held in Phuket, Thailand, on 18-19 September, 1997 and in Boston, USA, on 23-24 April, 1998, supported by an educational grant from Boehringer Ingelheim. London: William Harvey Press, 1998.
Znajdź pełny tekst źródłaSouris, John. Synthesis of a potential bi-product analogue inhibitor for human plasma carboxypeptidase N. Sudbury, Ont: Laurentian University, 1985.
Znajdź pełny tekst źródłaShuffrey, Lauren Christine. Electrophysiological Marker of a Potential Excitatory/Inhibitory Imbalance in Children with Autism Spectrum Disorder. [New York, N.Y.?]: [publisher not identified], 2017.
Znajdź pełny tekst źródłaBates, Stephen Robert Edward. Potential inhibitors of zinc proteinases. 1985.
Znajdź pełny tekst źródłaDesign of Caspase Inhibitors as Potential Clinical Agents (Enzyme Inhibitors). CRC, 2008.
Znajdź pełny tekst źródłaAllen, Andrew David. The atomistic simulation of potential angiogenic inhibitors. 1996.
Znajdź pełny tekst źródłaMousa, Shaker A. Angiogenesis Inhibitors and Stimulators: Potential Therapeutic Implications. Taylor & Francis Group, 2000.
Znajdź pełny tekst źródłaLinton, Steven D., i Tom O'Brien. Design of Caspase Inhibitors As Potential Clinical Agents. Taylor & Francis Group, 2008.
Znajdź pełny tekst źródłaLinton, Steven D., i Tom O'Brien. Design of Caspase Inhibitors As Potential Clinical Agents. Taylor & Francis Group, 2008.
Znajdź pełny tekst źródłaLinton, Steven D., i Tom O'Brien. Design of Caspase Inhibitors As Potential Clinical Agents. Taylor & Francis Group, 2019.
Znajdź pełny tekst źródłaDesign of caspase inhibitors as potential clinical agents. Boca Raton: Taylor & Francis, 2009.
Znajdź pełny tekst źródłaSimons, Claire, H. John Smith i Steven D. Linton. Design of Caspase Inhibitors As Potential Clinical Agents. Taylor & Francis Group, 2008.
Znajdź pełny tekst źródła(Editor), H. John Smith, i Claire Simons (Editor), red. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development. CRC, 2002.
Znajdź pełny tekst źródłaSimons, Claire, i H. John Smith. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development. Taylor & Francis Group, 2002.
Znajdź pełny tekst źródłaSimons, Claire, i H. John Smith. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development. Taylor & Francis Group, 2002.
Znajdź pełny tekst źródłaSimons, Claire, i H. John Smith. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development. Taylor & Francis Group, 2002.
Znajdź pełny tekst źródłaSimons, Claire, i H. John Smith. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development. Taylor & Francis Group, 2002.
Znajdź pełny tekst źródłaSimons, Claire, i H. John Smith. Proteinase and Peptidase Inhibition: Recent Potential Targets for Drug Development. Taylor & Francis Group, 2002.
Znajdź pełny tekst źródłaVane, Sir John, red. Clinical Significance And Potential Of Selective Cox-2 Inhibitors. WILLIAM HARVEY PRESS, 1998.
Znajdź pełny tekst źródłaSharma, Sushil K. Monoamine Oxidase Inhibitors: Clinical Pharmacology, Benefits, and Potential Health Risks. Nova Science Publishers, Incorporated, 2016.
Znajdź pełny tekst źródłaMousa, Shaker A. Angiogenesis Inhibitors and Stimulators: Potential Therapeutic Implications (Medical Intelligence Unit). Landes Bioscience, 2000.
Znajdź pełny tekst źródłaSir John R. Vane (Editor) i Jack H. Botting (Editor), red. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 1998.
Znajdź pełny tekst źródłaBotting, Jack H., i Sir John R. Vane. Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential. Springer, 2012.
Znajdź pełny tekst źródła(Editor), Walter H. Hörl, i August Heidland (Editor), red. Proteases II: Potential Role in Health and Disease (Advances in Experimental Medicine and Biology). Springer, 1989.
Znajdź pełny tekst źródłaFleischmann, Roy. Signalling pathway inhibitors. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081.
Pełny tekst źródłaBiotransformation Potential and Uncoupling Behavior of Common Benzotriazole-Based Corrosion Inhibitors. Storming Media, 2002.
Znajdź pełny tekst źródłaOnuigbo, Macaulay Amechi. ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects and Related Topics. Volume 1. Nova Science Publishers, Incorporated, 2015.
Znajdź pełny tekst źródła(Editor), Robert A. Greenwald, New York Academy of Sciences (Corporate Author) i Lorne M. Golub (Editor), red. Inhibition of Matrix Metalloproteinases: Therapeutic Potential (Annals of the New York Academy of Sciences). New York Academy of Sciences, 1994.
Znajdź pełny tekst źródła1st, Naga Raju Chinthakunta, Suresh Kumar Chitta 2nd, Anuradha C. M. 3rd i Rajani Vallepu IV. In Silico Screening of Natural Compounds As Potential Inhibitors of GPR120 to Prevent Cancer. INSC International Publisher (IIP), 2021.
Znajdź pełny tekst źródła(Editor), Robert A. Greenwald, New York Academy of Sciences (Corporate Author) i Lorne M. Golub (Editor), red. Inhibition of Matrix Metalloproteinases: Therapeutic Potential (Annals of the New York Academy of Sciences, Vol 732). New York Academy of Sciences, 1994.
Znajdź pełny tekst źródłaSelective COX-2 inhibitors: Pharmacology, clinical effects, and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Dordrecht: Kluwer Academic, 1998.
Znajdź pełny tekst źródłaR, Vane John, Botting Jack H i William Harvey Research Conference (1997 : Cannes, France), red. Selective COX-2 inhibitors: Pharmacology, clinical effects and therapeutic potential : proceedings of a conference held on March 20-21, 1997, in Cannes, France. Dordrecht: Kluwer Academic, 1998.
Znajdź pełny tekst źródłaOnuigbo, Macaulay Amechi. ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects and Related Topics -- Volume 1. Nova Science Publishers, Incorporated, 2013.
Znajdź pełny tekst źródłaOnuigbo, Macaulay Amechi. ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects and Related Topics -- Volume 2. Nova Science Publishers, Incorporated, 2013.
Znajdź pełny tekst źródłaOnuigbo, Macaulay Amechi, i Macaulay Amechi Chuka Onuigbo. ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects and Related Topics. Volume 2. Nova Science Publishers, Incorporated, 2015.
Znajdź pełny tekst źródłaRegulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy. Springer, 2006.
Znajdź pełny tekst źródła